Kronos Bio, Inc. (KRON)

Last Closing Price: 0.96 (2024-04-24)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Kronos Bio, Inc. (KRON) had Net Income of $-112.67M for the most recently reported fiscal year, ending 2023-12-31.

Figures for fiscal year ending 2023-12-31
Income Statement Financials
$6.29M
Net Income
$-112.67M
--
$6.29M
$128.12M
$-121.83M
$9.16M
$-112.67M
$-112.67M
$-112.67M
$-112.67M
$-112.67M
$-112.67M
$-121.83M
$-122.12M
57.74M
57.74M
$-1.95
$-1.95
Balance Sheet Financials
$178.78M
$10.25M
$34.50M
$213.28M
$24.70M
--
$29.51M
$54.20M
$159.08M
$159.08M
$159.08M
58.95M
Cash Flow Statement Financials
$-78.58M
$66.37M
$0.57M
$78.00M
$66.35M
$-11.65M
$24.98M
--
--
Fundamental Metrics & Ratios
7.24
--
--
--
--
100.00%
-1937.50%
-1937.50%
-1942.10%
-1791.87%
-1791.87%
$-79.26M
--
--
--
0.03
--
--
--
-70.83%
-70.83%
-52.83%
-70.83%
$2.70
$-1.37
$-1.36